Therapeutic targets for preventing non-alcoholic fatty liver disease
Uncleavable Mertk knock-in mouse for studying cardiovascular and neuroinflammatory disease
Diabetes drug as a candidate for treatment of obesity and other metabolic diseases
Treatment of obesity and diabetes through the inhibition of MAPKAPK2 and MAPKAPK3
Nanoparticles for targeted delivery of anti-inflammatory agents
Copyright © 2018 Ira Tabas, MD, PhD. All Rights Reserved.